Cognitive Impairments Related to COMT and Neuregulin 1 Phenotypes as Transdiagnostic Markers in Schizophrenia Spectrum Patients

Research on the interaction between antipsychotic treatment and cognitive dysfunction in schizophrenia spectrum disorders (SSDs) is extensive, yet the role of genetic polymorphisms in catechol-O-methyltransferase (COMT) and neuregulin 1 (NRG1) remains underexplored. : This study evaluates the impact...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical medicine 2024-10, Vol.13 (21), p.6405
Hauptverfasser:	Bondrescu, Mariana, Dehelean, Liana, Farcas, Simona Sorina, Papava, Ion, Nicoras, Vlad, Podaru, Carla Andreea, Sava, Madalina, Bilavu, Elena Sabina, Putnoky, Sandra, Andreescu, Nicoleta Ioana
Format:	Artikel
Sprache:	eng
Schlagworte:	Cognition & reasoning Cognition disorders Cognitive ability Consent Diagnosis Disease Dopamine Enzymes Epidermal growth factor Executive function Genetic aspects Genetic polymorphisms Genotype & phenotype Health aspects Memory Methyltransferases Neurons Psychological aspects Psychopathology Psychosis Schizophrenia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!